Jeremy O’Connor

Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)

Jonas A. de Souza, Bonnie J. Yap, Kristen Wroblewski et al. · Cancer · 2016 · 882 citations · Full text

Medicine, Oncology, Chemotherapy +16

Factors Associated With Cancer Disparities Among Low-, Medium-, and High-Income US Counties

Jeremy O’Connor, Tannaz Sedghi, Meera M. Dhodapkar et al. · JAMA Network Open · 2018 · 117 citations · Full text

Public Health, Oncology, Population Health Sciences +17

Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials

Jeremy O’Connor, Kristen L. Fessele, Jean Steiner et al. · JAMA Oncology · 2018 · 110 citations · Full text

Medicine, Oncology, Pharmacology +17

Determinants of Patient-Centered Financial Stress in Patients With Locally Advanced Head and Neck Cancer

Jonas A. de Souza, Sunny Kung, Jeremy O’Connor et al. · Journal of Oncology Practice · 2017 · 60 citations · Full text

Medicine, Oncology, Cancer Symptom Management +14

Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors

Jeremy O’Connor, Kathi Seidl-Rathkopf, Aracelis Z. Torres et al. · The Oncologist · 2018 · 25 citations · Full text

Medicine, Immunology, Oncology +17